Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058326) titled 'Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review' on June 30.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Shiroishi Tomo Mental Clinic,Department of Psychiatry,ISHIDA Tetsuro
Condition:
Condition - Delirium,Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To systematically map existing literature on the use of asenapine for delirium in patients with cancer.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female...